Skip to main content
Equibles

OPPENHEIMER & CO INC

Position in VERU — Veru Inc.

CIK 822581 NEW YORK, NY
Back to VERU Full portfolio

Position in VERU

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$659,938
+$226,115 QoQ
Shares Held
210,843
+7.4% QoQ
Ownership
1.24%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#3
of 61 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VERU Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

OPPENHEIMER & CO INC holds $50,552,262 across 50 Biotechnology names. VERU ranks #16 (1.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 22,129 $13,798,316
2 VKTX
Viking Therapeutics, Inc.
 146,259 $5,705,563
3 RVMD
Revolution Medicines, Inc.
 15,400 $2,884,112
4 TYRA
Tyra Biosciences, Inc.
 83,783 $2,676,029
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 4,250 $2,111,102
6 TRVI
Trevi Therapeutics, Inc.
 99,771 $1,860,729
7 CAPR
Capricor Therapeutics, Inc.
 75,714 $1,823,193
8 NTLA
Intellia Therapeutics, Inc.
 107,453 $1,818,104

All Filings in VERU

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $659,938 210,843
2026-03-31 $433,823 196,300
2025-12-31 $423,454 197,876
2025-09-30 $730,238 192,168
2025-06-30 $761,552 1,313,021
2025-03-31 $649,370 1,325,246
2024-12-31 $728,380 1,120,586
2024-09-30 $306,415 397,942
2024-06-30 $449,685 535,340
2024-03-31 $8,650 12,358
2023-12-31 $15,479 21,499
2023-09-30 $20,424 28,368
2023-06-30 $28,402 23,868
2023-03-31 $31,082 26,795
2022-12-31 $129,534 24,533
2022-09-30 $267,045 23,181
2021-12-31 $113,052 19,194
2021-09-30 $260,514 30,541
2021-06-30 $561,341 69,559
2021-03-31 $465,501 43,182
2020-06-30 $138,185 41,373
2020-03-31 $135,289 41,373